结构治疗 GPCR
$20.35 +$1.27 (+6.66%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $20.00 -1.72%
开盘$19.44
昨收$19.08
当日区间$18.70 – $21.31
成交量1.62M
市值$1.45B
市盈率（TTM）–
股息率–
GPCR 相关新闻
匹配 Structure Therapeutics 或代码 GPCR 的头条新闻，按最新排序。
- Canaccord Genuity Remains a Buy on Structure Therapeutics, Inc. Sponsored ADR (GPCR)
- CCORF Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $111
- H.C. Wainwright Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $70
- Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR), Belite Bio, Inc. ADR (BLTE) and BridgeBio Oncology Therapeutics (BBOT)
- Analysts Are Bullish on These Healthcare Stocks: EnGene Holdings (ENGN), Structure Therapeutics, Inc. Sponsored ADR (GPCR) 正面
- A Quick Look at Today's Ratings for Structure Therapeutics(GPCR.US), With a Forecast Between $70 to $125
- A Quick Look at Today's Ratings for Structure Therapeutics(GPCR.US), With a Forecast Between $70 to $111
- Jefferies Remains a Buy on Structure Therapeutics, Inc. Sponsored ADR (GPCR)
- A Quick Look at Today's Ratings for Structure Therapeutics(GPCR.US), With a Forecast Between $97 to $145
- J.P. Morgan Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Announces Target Price $100
- Morgan Stanley Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $126
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Oculis Holding (OCS), Stevanato Group (STVN) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)
- Citi Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $97
- XTALPI: VOLUNTARY ANNOUNCEMENTSTRATEGIC PARTNERSHIP WITH A LEADING BIOPHARMA COMPANYTO DEVELOP ORAL SMALL MOLECULE THERAPEUTICSFOR A GPCR TARGET, WITH A TOTAL POTENTIAL DEAL VALUE OFOVER US$400 MILLION 正面
- J.P. Morgan Maintains Structure Therapeutics(GPCR.US) With Buy Rating
暂无评论——快来第一个聊聊 GPCR。
登录后参与讨论。